5 risultati
FIELD OF THE INVENTION
The present invention relates to synergistic compositions for curing or preventing lipoxygenase mediated and free radical mediated disorders in mammals and various forms of degenerative musculoskeletal diseases such as rheumatoid arthritis and osteoarthritis. The present
FIELD OF THE INVENTION
The present invention relates to synergistic compositions for curing or preventing lipoxygenase mediated and free radical mediated disorders in mammals and various forms of degenerative musculoskeletal diseases such as rheumatoid arthritis and osteoarthritis. The present
FIELD OF INVENTION
The present invention provides synergistic nutraceutical, pharmaceutical and dietary supplement compositions comprising Boswellia serrata extract selectively enriched in 3-O-acetyl-11-keto-.beta.-boswellic acid (AKBA) and Boswellia serrata non-acidic resin extract (BNRE). The
DESCRIPTION OF FIGURES
FIG. IA: Representative Immunoblot shows LI-51255 [N-(3-O-Acetyl-11-ketoboswelloyl)-ethylenediamine (21)] down-regulates VEGF protein expression in HUVEC human endothelial cells. Bar graph shows normalized VEGF expression in respective treatments.
FIG. IB: LI-51255
TECHNICAL FIELD
The present invention provides methods comprising administration of: (i) 3-O-acetyl-11-keto-.beta.-boswellic acid (AKBA) and (ii) hydroxytyrosol, to a mammalian or an avian subject. The present invention also provides orally administrable compositions comprising AKBA and